Dove DermaSeries Intense Repairing Body Cream
- Manufacturer
- Conopco Inc. d/b/a Unilever
- Effective date
- 2022-11-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 23:51:48
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Dimethicone (6.0%)
OTC - PURPOSE SECTION
Purpose
Skin protectant
INDICATIONS & USAGE SECTION
Uses
● temporarily protects and helps relieve chapped or cracked skin.
● helps protect from the drying effects of wind and cold weather.
WARNINGS SECTION
WARNINGS
For External Use Only.
OTC - WHEN USING SECTION
When using this product do not get into eyes.
OTC - STOP USE SECTION
Stop use and ask a doctor if ● condition worsens ● symptoms last more than 7 days or clear up and occur again within a few days
OTC - DO NOT USE SECTION
Do not use on
● deep or puncture wounds
● animal bites
● serious burns
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions
● apply as needed.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Water (Aqua), Glycerin, Hydroxystearic Acid, Sodium Hydroxypropyl Starch Phosphate, Isopropyl Myristate, Petrolatum, Cetearyl Alcohol, Glyceryl Hydroxystearate, Caprylyl Glycol, Phenoxyethanol, Stearic Acid, Citrus Limon (Lemon) Peel Powder, Cetearyl Glucoside, Citrus Aurantifolia (Lime) Peel Powder, Disodium EDTA, Titanium Dioxide (CI 77891).
OTC - QUESTIONS SECTION
Questions?
Call 1-800-761-DOVE (3683)
6.8 FL. OZ. PDP
6.8 FL. OZ. Carton
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 577215 | dimethicone 6 % Topical Cream | PSN | 3 |
| 1440021 | Dove DermaSeries 6 % Topical Cream | PSN | 3 |
| 1440021 | dimethicone 60 MG/ML Topical Cream [Dove DermaSeries] | SBD | 3 |
| 577215 | dimethicone 60 MG/ML Topical Cream | SCD | 3 |
| 577215 | dimethicone 6 % Topical Cream | SY | 3 |
| 1440021 | Dove DermaSeries 6 % Topical Cream | SY | 3 |
| 1440021 | Dove DermaSeries 60 MG/ML Topical Cream | SY | 3 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64942-1307-2 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-3eaa-f424-e053-dadaa90a57ce | Dove DermaSeries Intense Repairing Body Cream |
| 64942-1307-2 | 2022-11-23 | C162847 | 48780-1 | 9d75b9d0-3eaa-f424-e053-dadaa90a57ce | Dove DermaSeries Intense Repairing Body Cream |
| 64942-1307-2 | 2022-07-29 | C162847 | 48780-1 | 9d75b9d0-3eaa-f424-e053-dadaa90a57ce | Dove DermaSeries Intense Repairing Body Cream |
| 64942-1307-2 | 2021-03-07 | C162847 | 48780-1 | 9d75b9d0-3eaa-f424-e053-dadaa90a57ce | Dove DermaSeries Intense Repairing Body Cream |
| 64942-1307-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3eaa-f424-e053-dadaa90a57ce | Dove DermaSeries Intense Repairing Body Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64942-1307-1 | Dove DermaSeriesIntense Repairing Body Cream | 200 mL in 1 BOTTLE, PUMP | CREAM | 200 | 3 | |
| 64942-1307-2 | Dove DermaSeriesIntense Repairing Body Cream | 1 in 1 CARTON | CREAM | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64942-1307 | DOVE DERMASERIES INTENSE REPAIRING BODY CREAM (DIMETHICONE) CREAM [CONOPCO INC. D/B/A UNILEVER] | 3 | Legacy NDC, 2 package rows | 20221124_5494c9dd-4cf1-4c44-b846-930324d7c766.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DIMETHICONE | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIMETHICONE | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| 12-HYDROXYSTEARIC ACID | INACTIVE INGREDIENT | 933ANU3H2S | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 1 | |
| LEMON PEEL | INACTIVE INGREDIENT | 72O054U628 | 1 | |
| LIME PEEL | INACTIVE INGREDIENT | 544EQK5Q0W | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Dove DermaSeries Intense Repairing Body Cream
- Dimethicone
- WATER
- GLYCERIN
- 12-HYDROXYSTEARIC ACID
- ISOPROPYL MYRISTATE
- PETROLATUM
- CETOSTEARYL ALCOHOL
- CAPRYLYL GLYCOL
- PHENOXYETHANOL
- STEARIC ACID
- LEMON PEEL
- CETEARYL GLUCOSIDE
- LIME PEEL
- EDETATE DISODIUM
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64942-1307 | 64942-1307-1, 64942-1307-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| 12-HYDROXYSTEARIC ACID | 933ANU3H2S | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| CETOSTEARYL ALCOHOL | 2DMT128M1S | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| LEMON PEEL | 72O054U628 | IACT |
| CETEARYL GLUCOSIDE | 09FUA47KNA | IACT |
| LIME PEEL | 544EQK5Q0W | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| DIMETHICONE | 92RU3N3Y1O | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | OINTMENT / TOPICAL | 1 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, EXTENDED RELEASE / ORAL | 67 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / TOPICAL | 213 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OINTMENT / TOPICAL | 35 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / NASAL | 0.1 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / AURICULAR (OTIC) | 36 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | FILM / TRANSDERMAL | 58.08 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL, METERED / TRANSDERMAL | 50 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TRANSDERMAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ELIXIR / ORAL | 1.3 mg/5ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ee244c09-7653-173d-e053-2a95a90a16b1 | 5494c9dd-4cf1-4c44-b846-930324d7c766 | 2022-11-23 | Warnings | ee244c09-7653-173d-e053-2a95a90a16b1 5494c9dd-4cf1-4c44-b846-930324d7c766 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

